BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 22313379)

  • 1. Pathology of demyelinating diseases.
    Popescu BF; Lucchinetti CF
    Annu Rev Pathol; 2012; 7():185-217. PubMed ID: 22313379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
    Kira J
    Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic criteria of borderline forms of multiple sclerosis].
    Dupel-Pottier C
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):935-43. PubMed ID: 11787358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological differences in acute inflammatory demyelinating diseases of the central nervous system.
    Wegner C
    Int MS J; 2005 Apr; 12(1):13-9, 12. PubMed ID: 15955274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis.
    Dale RC; Brilot F; Banwell B
    Curr Opin Neurol; 2009 Jun; 22(3):233-40. PubMed ID: 19434783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric Multiple Sclerosis: Distinguishing Clinical and MR Imaging Features.
    Tenembaum SN
    Neuroimaging Clin N Am; 2017 May; 27(2):229-250. PubMed ID: 28391783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody signatures in patients with histopathologically defined multiple sclerosis patterns.
    Stork L; Ellenberger D; Ruprecht K; Reindl M; Beißbarth T; Friede T; Kümpfel T; Gerdes LA; Gloth M; Liman T; Paul F; Brück W; Metz I
    Acta Neuropathol; 2020 Mar; 139(3):547-564. PubMed ID: 31950335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early disruption of glial communication via connexin gap junction in multiple sclerosis, Baló's disease and neuromyelitis optica.
    Masaki K
    Neuropathology; 2015 Oct; 35(5):469-80. PubMed ID: 26016402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis.
    Wingerchuk DM; Lucchinetti CF
    Curr Opin Neurol; 2007 Jun; 20(3):343-50. PubMed ID: 17495631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of multiple sclerosis and related inflammatory demyelinating diseases.
    Kutzelnigg A; Lassmann H
    Handb Clin Neurol; 2014; 122():15-58. PubMed ID: 24507512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Astrocytopathy in neuromyelitis optica, multiple sclerosis and Baló's disease].
    Matsushita T; Masaki K; Suzuki S; Matsuoka T; Yonekawa T; Wu XM; Tabira T; Iwaki T; Kira J
    Rinsho Shinkeigaku; 2011 Nov; 51(11):898-900. PubMed ID: 22277409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular pathology of multiple sclerosis and neuromyelitis optica].
    Masaki K
    Nihon Rinsho; 2014 Nov; 72(11):1909-17. PubMed ID: 25518370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple sclerosis: clinical aspects, acute disseminated encephalomyelitis, neuromyelitis optica and other inflammatory variants].
    de Seze J
    Rev Neurol (Paris); 2007 Jun; 163(6-7):647-50. PubMed ID: 17607183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.
    Kira J
    J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathology of multiple sclerosis: evidence for heterogeneity.
    Morales Y; Parisi JE; Lucchinetti CF
    Adv Neurol; 2006; 98():27-45. PubMed ID: 16400825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory demyelinating diseases of the central nervous system.
    Höftberger R; Lassmann H
    Handb Clin Neurol; 2017; 145():263-283. PubMed ID: 28987175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct microglial and macrophage distribution patterns in the concentric and lamellar lesions in Baló's disease and neuromyelitis optica spectrum disorders.
    Hayashida S; Masaki K; Suzuki SO; Yamasaki R; Watanabe M; Koyama S; Isobe N; Matsushita T; Takahashi K; Tabira T; Iwaki T; Kira JI
    Brain Pathol; 2020 Nov; 30(6):1144-1157. PubMed ID: 32902014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumefactive demyelinating lesions.
    Dagher AP; Smirniotopoulos J
    Neuroradiology; 1996 Aug; 38(6):560-5. PubMed ID: 8880719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Other demyelinating diseases.
    Tselis AC; Lisak RP
    Adv Neurol; 2006; 98():335-49. PubMed ID: 16400843
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
    Wegner C
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.